Home / Recalls / Ferring Pharmaceuticals Inc / D-0879-2023

D-0879-2023 Class II Terminated

Recalled by Ferring Pharmaceuticals Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
July 5, 2023
Initiation Date
June 12, 2023
Termination Date
August 5, 2024
Voluntary/Mandated
N/A
Product Quantity
N/A

Product Description

Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03

Reason for Recall

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Distribution Pattern

USA Nationwide

Code Information

AA200A, AA201A, Exp. 12/2025

Other recalls by Ferring Pharmaceuticals Inc

  • D-0318-2021 Class II — ZOMA-Jet 10 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (March 11, 2021)
  • D-0317-2021 Class II — ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (March 11, 2021)
  • D-0299-2021 Class III — Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials o (March 2, 2021)
  • D-1505-2020 Class I — Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, R (July 21, 2020)
  • D-1506-2020 Class I — STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spra (July 21, 2020)
  • D-1504-2020 Class I — DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, M (July 21, 2020)
  • D-0015-2016 Class III — Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intr (September 9, 2015)
  • D-1385-2014 Class II — TEV-TROPIN [somatropin (rDNA origin) for injection] 5 mg (15 IU) 1-count bottle, (April 28, 2014)
  • D-1426-2014 Class III — ENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufa (September 19, 2013)
  • D-240-2013 Class III — TEV-TROPIN (somatropin (rDNA origin) for injection) 5 mg (15 IU). Prescription (February 1, 2013)